510(k) Report

510(k) · Cleared

Cleared

Tina-quant Cystatin C Gen.2

K161817510(k) SpecialCleared Jul 27, 201626-day reviewClass II21 CFR 862.1225

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Roche Diagnostics Operations (Rdo) · NDY Test, Cystatin C

Cleared on Jul 27, 2016 as substantially equivalent to K141143 (Roche Diagnostics, 2014) after a 26-day review. Its family tree reaches back 4 generations to 1995. 1 later device descends from it.

Decided
Jul 27, 2016
Review
26 days
Class
Class II
Product code
NDY
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to K953239 (1995). 7 ancestors in all. 1 later device descends from it, 1 citing it directly.

  1. Root · 4 generations backK953239 Boehringer Mannheim/Hitachi 917 AnalyzerBoehringer Mannheim Corp. · 1995 · Recalled
  2. 3 generations backK041627 Cystatin C Immunoparticles, Control Set, CalibratorDako A/S · 2004
  3. 2 generations backK080811 Tina-Quant Cystatin C, Calibrator F.a.S. Cystatin C and Cystatin C…Roche Diagnostics Corp. · 2008
  4. 1 generation backK141143 Cobas C Tina-Quant Cystatin C Gen.2 Assay, C.F.a.S. Cystatin C…Roche Diagnostics · 2014
  5. This deviceK161817 Tina-quant Cystatin C Gen.2Roche Diagnostics Operations (Rdo) · 2016
  6. Descendant · cites it directly · 0 of its ownK242585 Cystatin CSENTINEL CH. SpA · 2025

Most influential descendants

Showing 1 of 1 · See all
  • K242585Cystatin CSENTINEL CH. SpA · 2025 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K953239Boehringer Mannheim/Hitachi 917 AnalyzerBoehringer Mannheim Corp.199518
−3K041627Cystatin C Immunoparticles, Control Set, CalibratorDako A/S2004—
−2K080811Tina-Quant Cystatin C, Calibrator F.a.S. Cystatin C and Cystatin C Andcystatin…Roche Diagnostics Corp.2008—
−1K141143Cobas C Tina-Quant Cystatin C Gen.2 Assay, C.F.a.S. Cystatin C Calibrator…Roche Diagnostics2014—
0 (this device)K161817Tina-quant Cystatin C Gen.2Roche Diagnostics Operations (Rdo)2016—
+1K242585Cystatin CSENTINEL CH. SpA2025—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200120
201010

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202510
FIG. 1 — Lineage of K161817, 1995–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NDY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NDY device

  1. #1 K242585 Cystatin Cscore 10.5 · 5 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K141143Cobas C Tina-Quant Cystatin C Gen.2 Assay, C.F.a.S. Cystatin C Calibrator, Cystatin C…
Summary page 5
…predicate device. The Predicate Devices device name, Tina-quant Cystatin C Gen.2, is unchanged from how it was cleared in 510(k) K141143 For the Tina-quant Cystatin C Gen.2, the establishment registration num…
Roche Diagnostics2014—

Also cleared against K141143: 1 other device →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K242585Cystatin CSENTINEL CH. SpA20250

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 21 years and passes through 5 companies; a new generation was cleared every 6.1 years on median.
  • 1 of the 7 ancestors has a recall of any class.
  • Of its descendants, K242585 (SENTINEL CH. SpA, 2025) has gone furthest, with 0 descendants of its own.
  • 1 other device also cites its predicate K141143.

How does its category compare?

All NDY devices

NDY Test, Cystatin C: FDA decisions, review times, recalls and adverse event reports over 20 years. 2016, this device’s year, is highlighted.

FDA decisions per year · NDY

1in 2025

2007: 32008: 62009: 12010: 32012: 12014: 12016: 12017: 12018: 12025: 1
2007high 6 (2008) · low 0 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NDY

265in 2010

2007: 95 days median2008: 101 days median2010: 265 days median
2007high 265 (2010) · low 95 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NDY

1in 2020

2020: 1
2007high 1 (2020) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NDY

10in 2025

2015: 12016: 12017: 22019: 12023: 22024: 32025: 10
2007high 10 (2025) · low 0 (2007)2025

MAUDE reports naming product code NDY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200739500
2008610100
20091—00
2010326500
20110—00
20121—00
20130—00
20141—00
20150—01
20161—01
20171—02
20181—00
20190—01
20200—10
20210—00
20220—00
20230—02
20240—03
20251—010
20260—0—

What is it indicated for?

Tina-quant Cystatin Gen.2 is an in vitro test for the quantitative determination of cystatin C in human serum and plasma on Roche/Hitachi cobas c systems. Cystatin C measurements are used as an aid in the diagnosis and treatment of renal diseases.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K161817: Tina-quant Cystatin C Gen.2.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K161817

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026